Research Grants

2020 Antiviral Development for COVID-19 (GO3825)

This grants asks for proposals of research to rapidly identify antiviral candidates targeting SARS-CoV-2 (new and repurposed) and accelerate promising effective treatments that can be made available to treat Australians infected with SARS-CoV-2.

A competitive two stage funding process will be used:

Stage 1: Funding of up to $3 million will be provided to support testing of up to 10 antiviral candidates for stability, safety and effectiveness against SARS-CoV-2 to demonstrate proof of concept. Stage 1 projects are to be completed within 9 months of commencement.

Stage 2: Funding of up to $5 million will support acceleration of promising antiviral candidates from Stage 1 into clinical practice, enabling clinical trials in humans, progression through regulatory pathways and/or transition to commercialisation. Stage 2 projects are to be completed within 24 months of commencement.

Applicants should note that the research funded by this grant opportunity is not intended to be used for vaccine development or respiratory medicine research for COVID-19. These issues are the subject of separate MRFF grant opportunities.

Applications will only be accepted from NHMRC approved Administering Institutions. A list of NHMRC approved Administering Institutions is available on GrantConnect and on the NHMRC website:

Total grant amount $8 million.

Closes 8 April 2020

For grant guidelines, please click here.


e-ASIA Joint Research Program 2020 (GO3772)

The e-ASIA JRP supports international joint research projects in the East Asia region.  This program is calling for research in the following areas: infectious diseases, mental health, cancer and climate change impact on human health.

Applications will only be accepted from NHMRC-approved Administering Institutions.  A list of these institutions can be found here.

The total grant amount is $3m and individual grant amounts can be up to $3m over three years.

Closes 29 April 2020

For Grant Guidelines, please click here.


Ideas Grants (GO3777)

The objective of this grant is to support innovative research projects that address a specific question.  The desired outcome will be to fund creative research in any area of health and medicine from discovery to implementation.  In particular, it provides opportunities for early and mid-career researchers.

The Ideas Grant scheme is not intended to support research where a clinical trial or cohort study is the primary objective. Applicants conducting projects which incorporate elements of clinical trial and/or cohort study must consider whether the project goals are more applicable to the Ideas Grant or Clinical Trials and Cohort Grant schemes. 

Applications will only be accepted from NHMRC-approved Administering Institutions.  A list of these institutions can be found here.

The total grant amount is $250m.

Closes 6 May 2020

For Grant Guidelines, please click here.


Linkage Research Projects (GO3426)

The Linkage Program promotes national and international research partnerships between researchers and business, industry, community organisations and other publicly funded research agencies. By supporting long-term strategic research partnerships, the Australian Research Council encourages alliances that solve problems, acquire new knowledge and allow the transfer of skills and ideas as a basis for securing commercial benefits of research.

The Linkage Projects scheme objectives are to:

  • support long-term strategic research alliances between higher education organisations and industry/business and other research end-users, in order to apply advanced knowledge to problems
  • provide opportunities for internationally competitive research projects to be conducted in collaboration with organisations outside the higher education sector
  • enhance the scale and focus of research in Australian Government priority areas.

The intended outcomes of the Linkage Projects scheme are:

  • the growth of a national pool of world-class researchers to meet the needs of the broader Australian innovation system
  • economic, commercial, environmental, social and/or cultural benefits for Australia.
Closes 1 December 2020